Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 386, Issue 8, pp 705–710

Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats

Original Article

Abstract

Oxidative stress and inflammation have been implicated in cerebral ischemia/reperfusion injury and complication of diabetes. The present study was designed to evaluate whether resveratrol has cerebroprotective action through antioxidant and anti-inflammatory actions in diabetic rats. Bilateral common carotid artery occlusion (30 min) and reperfusion (4 h) was employed to induce cerebral infarction in diabetic Wistar rats. Diabetes was induced by streptozocine (50 mg/kg) intraperitoneally at once. Diabetic animals were divided into groups as: normal, sham, ischemia–reperfusion, and resveratrol-treated (5, 10, 20, and 30 mg/kg). These were used for estimation of cerebral infarction. Furthermore, 20 mg/kg dose was selected for estimation of oxidative stress markers (malondialdehyde, superoxide dismutase, and catalase). Inflammatory markers like TNF-α, IL-6, IL-10, and myeloperoxidase were estimated and histological characters were studied. Resveratrol produced dose-dependent reduction in percent cerebral infarction. With resveratrol of 20 mg/kg dose, levels of oxidative stress markers and inflammatory markers like malondialdehyde, TNF-α, IL-6, and myeloperoxidase were reduced and there was a significant increase in the levels of antioxidant and anti-inflammatory markers like catalase, superoxide dismutase, and IL-10. In the present study, we found that mechanism(s) responsible for the cerebroprotective effect of resveratrol in the diabetic rat brain involves antioxidant and anti-inflammatory actions.

Keywords

Diabetes Ischemia–reperfusion injury Inflammation Oxidative stress 

References

  1. Aebi H (1974) Catalase. In: Bergmer HU (ed) Methods in enzymatic analysis, vol 2. Academic, New York, pp 673–684CrossRefGoogle Scholar
  2. Aggarwal BB, Bhardwai A, Aggarwal RS et al (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–40PubMedGoogle Scholar
  3. Andrabi SA, Spina MG, Lorenz P et al (2004) Oxyresveratrol (trans-2, 3′, 4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res 1017:98–7PubMedCrossRefGoogle Scholar
  4. Canbaz S, Duran E (2003) Ischaemia–reperfusion studies and diabetes mellitus. Br J Anaesth 91:158–159PubMedCrossRefGoogle Scholar
  5. Dawn B (2007) Resveratrol: ready for prime time? J Mol Cell Cardiol 42:484–486PubMedCrossRefGoogle Scholar
  6. de la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156–1160PubMedCrossRefGoogle Scholar
  7. Del Zoppo GJ (1997) Microvascular responses to cerebral ischemia/inflammation. Ann NY Acad Sci 823:132–147PubMedCrossRefGoogle Scholar
  8. Della-Morte D, Dave KR, DeFazio RA et al (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993–1002PubMedCrossRefGoogle Scholar
  9. Di Carlo A (2009) Human and economic burden of stroke. Age Ageing 38:4–5PubMedCrossRefGoogle Scholar
  10. Gouwy M, Struyf S, Proost P, Van Damme J (2005) Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 16:561–580PubMedCrossRefGoogle Scholar
  11. Iwasaki Y, Ito S, Suzuki M, Nagahori T, Yamamato T, Konno H (1989) Forebrain ischemia induced by temporary bilateral common carotid occlusion in normotensive rats. J Neurol Sci 90:155–5PubMedCrossRefGoogle Scholar
  12. Juhasz B, Varga B, Gesztelyi R et al (2010) Resveratrol: a multifunctional cytoprotective molecule. Curr Pharm Biotechnol 11:810–818PubMedCrossRefGoogle Scholar
  13. Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Ind J Bio Chem Biophys 21:130–132Google Scholar
  14. Kaste M (1997) Current therapeutic options for brain ischemia. Neurology 49:s56–s59PubMedCrossRefGoogle Scholar
  15. Khan M, Siphon B, Jatana M, Giri S et al (2004) Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76:519–7PubMedCrossRefGoogle Scholar
  16. Kim HK (1997) Experimental models of cerebral ischemia. Acta Anaesthesiol Scand Suppl 111:91–92PubMedGoogle Scholar
  17. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97PubMedCrossRefGoogle Scholar
  18. Liu N, Chen R, Du H, Wang J, Zhang Y, Wen J (2009) Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol Immunol 6:207–213PubMedCrossRefGoogle Scholar
  19. Markus MA, Morris BJ (2008) Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 2:331–339Google Scholar
  20. Mukherjee PK, Ahamed KF, Kumar V, Mukherjee K, Houghton PJ (2007) Protective effect of biflavones from Araucaria bidwillii Hook in rat cerebral ischemia/reperfusion induced oxidative stress. Behav Brain Res 178:221–228PubMedCrossRefGoogle Scholar
  21. Mullane KM, Bruce Smith ND (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157–7PubMedCrossRefGoogle Scholar
  22. Naylor AR (2011) Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:e385–e386PubMedCrossRefGoogle Scholar
  23. Okhawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefGoogle Scholar
  24. Orsu P, Murthy BV, Akula A (2013) Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm. doi:10.1007/s00702-013-0982-4
  25. Rock RB, Gekker G, Hu S et al (2004) Role of microglia in central nervous system infections. Clin Microbiol Rev 17:942–964PubMedCrossRefGoogle Scholar
  26. Saito K, Suyama K, Nishida K, Sei Y, Basile AS (1996) Early increases in TNF-alpha, IL-6 and IL-1 beta following transient cerebral ischemia in gerbil brain. Neurosci Lett 206:149–2PubMedCrossRefGoogle Scholar
  27. Sinha K, Chaudhary G, Gupta YK (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71:655–665PubMedCrossRefGoogle Scholar
  28. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H et al (2007) Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43:720–729PubMedCrossRefGoogle Scholar
  29. Tosaki A, Szerdahelyi P, Joo F (1994) Treatment with ranitidine of ischemic brain edema. Eur J Pharmacol 264:455–458PubMedCrossRefGoogle Scholar
  30. Tsuruta R, Fujita M, Ono T et al (2010) Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats. Brain Res 1309:155–3PubMedCrossRefGoogle Scholar
  31. Wang Y, Schmeichel AM, Iida H, Schmelzer JD, Low PA (2005) Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy. Antioxid Redox Signal 7:1513–1520PubMedCrossRefGoogle Scholar
  32. Wong CH, Crack PJ (2008) Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia–reperfusion injury. Curr Med Chem 15:1–14PubMedCrossRefGoogle Scholar
  33. Yasuda Y, Shimoda T, Uno K et al (2011) Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global ischemia in rats. J Neuroinflammation 8:70PubMedCrossRefGoogle Scholar
  34. Yousuf S, Atif F, Ahmad M et al (2007) Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res 1147:218–225PubMedCrossRefGoogle Scholar
  35. Zhang F, Liu J, Shi JS (2010) Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 636:1–7PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Srinivasarao College of PharmacyVisakhapatnamIndia

Personalised recommendations